Institutional Biosafety Committee

The NKU Institutional Biosafety Committee (IBC) must conduct a review of projects that fall into certain categories as outlined in the Biohazard Agent Registration (BAR) form. 

A BAR form must be completed for studies that fall into any of the categories below:

1. Construction and/or use of recombinant DNA, beyond accepted/standard (non-hazardous) practices, in standard host-vector systems
   
   
2. Toxins or infectious agents requiring handling conditions above Biosafety Level-1. (Biosafety Level determinations are outlined by the CDC publication Biosafety in Microbiological and Biomedical Laboratories.)

If there is a question as to whether or not the activity requires IBC review, the researcher should submit a description of the activity to the IBC Chair or IBC Administrator for final determination.

This summary should include:

1. Summary of the study
2. Amount of agent/drug to be used
3. Condition of use of agent/drug
4. Inactivation and disposal of agent/drug

Joe Mester, Ph.D.
IBC Chair

Mark Bardgett, Ph.D.
Faculty Member Representative

Nick Nieberding, B.S. 
Environmental Health/Safety Department Representative

Madeline Blevins, B.S.
Lab Technician

Michael Ware, Ph.D.
Genera Public Representative

Michael Guy, Ph.D.
Scientist

Sabine Zacate, Ph.D.
General Public Representative